ADA Updates Sample Notice to Align with HIPAA Rules Addressing Substance Use Disorder Records
Beginning February 16, 2026, HIPAA covered entities must include information in their Notice of Privacy Practices (NPP) describing how substance use disorder records may be used and disclosed. This requirement is the result of guidance set by the United States Department of Health and Human Services in April of 2024. The American Dental Association (ADA) has provided a checklist and made updates to its Sample Notice of Privacy Practices to reflect the updated requirement.
o Remember, compliance documentation must be retained 6 years from the date the document was created or from the date the document was no longer in effect, whichever is later.
The amended ADA NPP adds a section related to the use and disclosure of information related to substance use disorder treatment. It specifies that information from a substance use disorder treatment program covered by 42 CFR Part 2 (part 2 program) may be used and disclosed as permitted. This may take the form of a general consent related to healthcare operations, billing, and treatment provided to a part 2 program or a specific consent provided to the dental office or another third party.
The stated intention behind the new requirement is to, “reduce the need for data segmentation and tracking.” Previously, part 2 program records had to be siloed from other records due to strict limits on redisclosure. The new regulation allows patients to issue a single consent for future uses and disclosures for treatment, payment, and healthcare operations. It also allows covered entities and business associates receiving records under this consent to redisclose records in accordance with HIPAA regulations. Notably, part 2 program records cannot be used in a legal proceeding without a court order or specific consent.